Glen C. Balch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Glen C. Balch has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
John C. Mansour
Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
6 shared publicationsAdam C. Yopp
Department of Surgery
4 shared publicationsCharles M. Balch
Division of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
3 shared publicationsJaehoon Yu
Department of Physics, University of Texas at Arlington, Arlington, TX 76019 USA
3 shared publicationsMingwu Jin
Department of Physics, University of Texas at Arlington, Arlington, TX 76019 USA
3 shared publications- Robert Daniel Beauchamp
Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
3 shared publications
Latest Publications
- Open Access
- 18 March 2024
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 39 (1) , 1-12
Prophylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal Cancer Consortium
Purpose: Anastomotic leak (AL) is a complication of low anterior resection (LAR) that results in substantial morbidity. There is immense interest in evaluating immediate postoperative and long-term oncologic outcomes in patients who undergo diverting loop ileostomies (DLI). The purpose of this study is to understand the relationship between fecal diversion, AL, and oncologic outcomes. Methods: This is a retrospective multicenter cohort study using patient data obtained from the US Rectal Cancer Consortium database compiled from six academic institutions. The study population included patients with rectal adenocarcinoma undergoing LAR. The primary outcome was the incidence of AL among patients who did or did not receive DLI during LAR. Secondary outcomes included risk factors for AL, receipt of adjuvant therapy, 3-year overall survival, and 3-year recurrence. Results: Of 815 patients, 38 (4.7%) suffered AL after LAR. Patients with AL were more likely to be male, have unintentional preoperative weight loss, and are less likely to undergo DLI. On multivariable analysis, DLI remained protective against AL (p < 0.001). Diverted patients were less likely to undergo future surgical procedures including additional ostomy creation, completion proctectomy, or pelvic washout for AL. Subgroup analysis of 456 patients with locally advanced disease showed that DLI was correlated with increased receipt of adjuvant therapy for patients with and without AL on univariate analysis (SHR:1.59; [95% CI 1.19–2.14]; p = 0.002), but significance was not met in multivariate models. Conclusion: Lack of DLI and preoperative weight loss was associated with anastomotic leak. Fecal diversion may improve the timely initiation of adjuvant oncologic therapy. The long-term outcomes following routine diverting stomas warrant further study.
- 18 March 2024
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 39 (1) , 1-12
Open AccessProphylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal Cancer Consortium
Purpose: Anastomotic leak (AL) is a complication of low anterior resection (LAR) that results in substantial morbidity. There is immense interest in evaluating immediate postoperative and long-term oncologic outcomes in patients who undergo diverting loop ileostomies (DLI). The purpose of this study is to understand the relationship between fecal diversion, AL, and oncologic outcomes. Methods: This is a retrospective multicenter cohort study using patient data obtained from the US Rectal Cancer Consortium database compiled from six academic institutions. The study population included patients with rectal adenocarcinoma undergoing LAR. The primary outcome was the incidence of AL among patients who did or did not receive DLI during LAR. Secondary outcomes included risk factors for AL, receipt of adjuvant therapy, 3-year overall survival, and 3-year recurrence. Results: Of 815 patients, 38 (4.7%) suffered AL after LAR. Patients with AL were more likely to be male, have unintentional preoperative weight loss, and are less likely to undergo DLI. On multivariable analysis, DLI remained protective against AL (p < 0.001). Diverted patients were less likely to undergo future surgical procedures including additional ostomy creation, completion proctectomy, or pelvic washout for AL. Subgroup analysis of 456 patients with locally advanced disease showed that DLI was correlated with increased receipt of adjuvant therapy for patients with and without AL on univariate analysis (SHR:1.59; [95% CI 1.19–2.14]; p = 0.002), but significance was not met in multivariate models. Conclusion: Lack of DLI and preoperative weight loss was associated with anastomotic leak. Fecal diversion may improve the timely initiation of adjuvant oncologic therapy. The long-term outcomes following routine diverting stomas warrant further study.
- 1 October 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 266, 54-61
Elderly Patients Benefit From Enhanced Recovery Protocols After Colorectal Surgery
- 1 October 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 266, 54-61
Elderly Patients Benefit From Enhanced Recovery Protocols After Colorectal Surgery
- 1 August 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 252, 69-79
Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study
- 1 August 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 252, 69-79
Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study
- 14 June 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (8) , 2600-2613
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain f
- 14 June 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (8) , 2600-2613
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change
The COVID-19 pandemic has posed extraordinary demands from patients, providers, and health care systems. Despite this, surgical oncologists must maintain f
- 18 June 2019
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (3) , 389-396
Perioperative anxiety and depression in patients undergoing abdominal surgery for benign or malignant disease
Background and Objectives: Etiologies, levels, and associated factors of psychological distress in cancer patients facing surgery are poorly defined. We conducted a prospective comparative study of perioperative anxiety and depression in patients undergoing abdominal surgery for either malignant or benign disease.Methods: With Institutional Review Board approval, patients consenting for surgery at our institution were enrolled. Surveys were completed at a preoperative visit and within 2 weeks of a postoperative appointment. Participants listed their top three sources of anxiety, and completed the Patient Health Questionnaire‐9 and the General Anxiety Disorder‐7.Results: A total of 79 patients completed the preoperative assessment and 44 (58.7%) finished the postoperative survey. Forty‐one were male (51.9%), 12 (15.2%) had a psychiatric comorbidity (PSYHx), and 47 (59.5%) had cancer. Perioperative anxiety and depression did not differ by malignancy status. Patients were most concerned about surgery (22.5%) preoperatively and finances (27.9%) postoperatively. PSYHx, frailty, insurance status, and opioid use were all associated with perioperative psychological distress.Conclusions: Cancer patients did not have significantly higher levels of perioperative psychological distress compared with benign controls. Socioeconomic worries are prevalent throughout the perioperative period, and efforts to alleviate distress should focus on providing adequate counseling.
- 18 June 2019
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (3) , 389-396
Perioperative anxiety and depression in patients undergoing abdominal surgery for benign or malignant disease
Background and Objectives: Etiologies, levels, and associated factors of psychological distress in cancer patients facing surgery are poorly defined. We conducted a prospective comparative study of perioperative anxiety and depression in patients undergoing abdominal surgery for either malignant or benign disease.Methods: With Institutional Review Board approval, patients consenting for surgery at our institution were enrolled. Surveys were completed at a preoperative visit and within 2 weeks of a postoperative appointment. Participants listed their top three sources of anxiety, and completed the Patient Health Questionnaire‐9 and the General Anxiety Disorder‐7.Results: A total of 79 patients completed the preoperative assessment and 44 (58.7%) finished the postoperative survey. Forty‐one were male (51.9%), 12 (15.2%) had a psychiatric comorbidity (PSYHx), and 47 (59.5%) had cancer. Perioperative anxiety and depression did not differ by malignancy status. Patients were most concerned about surgery (22.5%) preoperatively and finances (27.9%) postoperatively. PSYHx, frailty, insurance status, and opioid use were all associated with perioperative psychological distress.Conclusions: Cancer patients did not have significantly higher levels of perioperative psychological distress compared with benign controls. Socioeconomic worries are prevalent throughout the perioperative period, and efforts to alleviate distress should focus on providing adequate counseling.
- 1 October 2018
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 41 (10) , 972-976
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma
There is interest in improving the tumoricidal effects of preoperative radiotherapy for rectal carcinoma by studying new radiosensitizers. The safety and toxicity profile of these combination regimens needs rigorous clinical evaluation. The primary objective of this study was to evaluate the toxicity of combining bavituximab, an antibody that targets exposed phosphatidylserine, with capecitabine and radiation therapy. Patients with stage II or III rectal adenocarcinoma were enrolled on a phase I study combining radiation therapy, capecitabine, and bavituximab. A standard 3+3 trial designed was used. In general, bavituximab was safe and well tolerated in combination with radiation therapy and capecitabine in the treatment of rectal adenocarcinoma. One patient at the highest dose level experienced a grade III infusion reaction related to the bavituximab. One tumor demonstrated a complete pathologic response to the combination treatment. Bavituximab is safe in combination with capecitabine and radiation therapy at the doses selected for the study. Further clinical investigation would be necessary to better define the efficacy of this combination.
- 1 October 2018
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 41 (10) , 972-976
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma
There is interest in improving the tumoricidal effects of preoperative radiotherapy for rectal carcinoma by studying new radiosensitizers. The safety and toxicity profile of these combination regimens needs rigorous clinical evaluation. The primary objective of this study was to evaluate the toxicity of combining bavituximab, an antibody that targets exposed phosphatidylserine, with capecitabine and radiation therapy. Patients with stage II or III rectal adenocarcinoma were enrolled on a phase I study combining radiation therapy, capecitabine, and bavituximab. A standard 3+3 trial designed was used. In general, bavituximab was safe and well tolerated in combination with radiation therapy and capecitabine in the treatment of rectal adenocarcinoma. One patient at the highest dose level experienced a grade III infusion reaction related to the bavituximab. One tumor demonstrated a complete pathologic response to the combination treatment. Bavituximab is safe in combination with capecitabine and radiation therapy at the doses selected for the study. Further clinical investigation would be necessary to better define the efficacy of this combination.
- 6 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-3
Spatial denoising methods for low count functional images
Portable functional imaging devices can be used in oncological surgeries to locate residual tumors for better patient recovery and survival. Taking the patient dose and the limited time of surgery into account, the count in such images could be very low. In this study, we investigate effectiveness of different spatial denoising methods, such as Gaussian filtering, bilateral filtering, Rudin-Osher and Fatemin (ROF) denoising, and non-local means filtering, on low count functional images. We also propose a new denoising method based on maximum a posteriori (MAP) criterion. The simulation study shows that the simple methods, such as Gaussian and bilateral filtering, may be as effective as the advanced searching or iterative methods as measured by the relative root mean square error when the count is low. Further investigations using more realistic simulations or real functional images and tumor detection performance are needed to evaluate these methods at high noise levels.
- 6 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-3
Spatial denoising methods for low count functional images
Portable functional imaging devices can be used in oncological surgeries to locate residual tumors for better patient recovery and survival. Taking the patient dose and the limited time of surgery into account, the count in such images could be very low. In this study, we investigate effectiveness of different spatial denoising methods, such as Gaussian filtering, bilateral filtering, Rudin-Osher and Fatemin (ROF) denoising, and non-local means filtering, on low count functional images. We also propose a new denoising method based on maximum a posteriori (MAP) criterion. The simulation study shows that the simple methods, such as Gaussian and bilateral filtering, may be as effective as the advanced searching or iterative methods as measured by the relative root mean square error when the count is low. Further investigations using more realistic simulations or real functional images and tumor detection performance are needed to evaluate these methods at high noise levels.
- 1 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Feasibility study of direct beta particle detection using gas electron multiplier
Portable nuclear imaging devices have been pursed for intraoperative localization and visualization of tumors for a complete removal of malignant tissues. In the proximity of the tumor site, beta imaging is advantageous over gamma imaging due to far less long-range contamination and no need of heavy metal collimation for a compact size. The traditional beta particle detection usually uses a thin scintillation layer coupled with photomultiplier tubes or solid-state detectors, which may lose efficiency due to the multiple conversion steps. In this work, we study the feasibility of direct beta particle detection using gas electron multiplier (GEM) detectors, which are highly sensitive to charged particles. The Geant4 Monte Carlo simulation package is used to simulate Copper-64 (Cu-64) beta particle transportation in different materials. Our simulation results demonstrate that GEM is feasible for direct detection of beta particles and the sensitivity of GEM to beta particles is much higher than gamma photons for certain GEM structures.
- 1 October 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Feasibility study of direct beta particle detection using gas electron multiplier
Portable nuclear imaging devices have been pursed for intraoperative localization and visualization of tumors for a complete removal of malignant tissues. In the proximity of the tumor site, beta imaging is advantageous over gamma imaging due to far less long-range contamination and no need of heavy metal collimation for a compact size. The traditional beta particle detection usually uses a thin scintillation layer coupled with photomultiplier tubes or solid-state detectors, which may lose efficiency due to the multiple conversion steps. In this work, we study the feasibility of direct beta particle detection using gas electron multiplier (GEM) detectors, which are highly sensitive to charged particles. The Geant4 Monte Carlo simulation package is used to simulate Copper-64 (Cu-64) beta particle transportation in different materials. Our simulation results demonstrate that GEM is feasible for direct detection of beta particles and the sensitivity of GEM to beta particles is much higher than gamma photons for certain GEM structures.
- Open Access
- 12 August 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (1) , 9-11
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The Need for Accessible Data in Real Time
- 12 August 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (1) , 9-11
Open AccessCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The Need for Accessible Data in Real Time